openPR Logo
Press release

Global Antihypertensive Drugs Market US$ 24.3 Billion 2021

08-22-2017 10:45 AM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Global Antihypertensive Drugs Market US$ 24.3 Billion 2021

The global antihypertensive drugs market expected to reach US$ 24.3 billion by 2021, steadily declining at CAGR 2.5% over the forecast period 2017-2021, mainly due to patent expiration of blockbuster drugs and increasing generic competition worldwide.

Antihypertensive drugs are used to treat high blood pressure and its complications, such as stroke and myocardial infarction. The most important and most widely used drugs include thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers. These drugs can prevent heart failure, kidney failure and acute stroke induced by hypertension and delay the development of atherosclerosis by controlling the blood pressure. Although clinical evidence shows calcium channel blockers and thiazide-type diuretics are preferred first-line treatments, an ACE inhibitor is recommended by NICE in the UK for those under 55 years old. Angiotensin II receptor blockers (ARBs) comprises several leading brands such as Benicar (olmesartan medoxomil), Diovan (valsartan) and Micardis (telmisartan). The ‘others’ category includes endothelin receptor antagonists such as Tracleer, Opsumit (bosentan and macitentan) and Letairis (ambrisentan). All drug classes, except fixed-dose combinations (FDCs), represent sales of monotherapies.

Browse Antihypertensive Drugs Market by Drug Class - Angiotensin II Receptor Blockers (ARBs), Angiotensin-converting Enzyme (ACE) Inhibitors, β-blockers, Calcium Channel Blockers (CCBs), Diuretics, Fixed-dose Combinations (FDCs), Others and Forecast 2017-2021 at
https://www.ihealthcareanalyst.com/report/antihypertensive-drugs-market/

The global antihypertensive drugs market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global antihypertensive drugs market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global antihypertensive drugs market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global antihypertensive drugs market and profiled in this report include Actelion (Nippon Shinyaku), Alvogen, Bayer, Bellerophon Therapeutics, Boehringer Ingelheim, Boryung Pharmaceutical (Stendhal), CJ Healthcare, Daiichi Sankyo, Gilead, Eli Lilly, HanAll Biopharma (Yuhan), Hanmi Pharmaceutical, JW Pharmaceutical, Kitov Pharmaceuticals, Kyowa Hakko Kirin, Lung Biotechnology, Nippon Shinyaku, Novartis, Pfizer, Stendhal, Reata Pharmaceuticals (Kyowa Hakko Kirin), Takeda, United Therapeutics, and Yuhan.

1. Drug Class
1.1. Angiotensin II Receptor Blockers (ARBs)
1.2. Angiotensin-converting Enzyme (ACE) Inhibitors
1.3. β-blockers
1.4. Calcium Channel Blockers (CCBs)
1.5. Diuretics
1.6. Fixed-dose Combinations (FDCs)
1.7. Others

2. Geography
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC
2.5. Rest of the World

3. Company Profiles
3.1. Actelion
3.2. Alvogen
3.3. Bayer
3.4. Bellerophon Therapeutics
3.5. Boehringer Ingelheim
3.6. Boryung Pharmaceutical
3.7. CJ Healthcare
3.8. Daiichi Sankyo
3.9. Gilead
3.10. Eli Lilly
3.11. HanAll Biopharma
3.12. Hanmi Pharmaceutical
3.13. JW Pharmaceutical
3.14. Kitov Pharmaceuticals
3.15. Kyowa Hakko Kirin
3.16. Lung Biotechnology
3.17. Nippon Shinyaku
3.18. Novartis
3.19. Pfizer
3.20. Stendhal
3.21. Reata Pharmaceuticals
3.22. Takeda
3.23. United Therapeutics
3.24. Yuhan

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/antihypertensive-drugs-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antihypertensive Drugs Market US$ 24.3 Billion 2021 here

News-ID: 678109 • Views: 402

More Releases from iHealthcareAnalyst, Inc.

Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by
Global Cerebrospinal Fluid Management Market to Reach 1.9 US$ billion by 2023 gr …
According to a new market research report (updated 2018) published by iHealthcareAnalyst, Inc., Cerebrospinal Fluid Management Market – Global CSF Products Analysis and Forecast 2018-2023, the global cerebrospinal fluid management market was valued at US$ 1,045 Million in 2013 and to reach US$ 1.9 billion by 2023, growing at a CAGR of 5.5% from 2018-2023. Visit the Global Cerebrospinal Fluid Management Market – Global Patient Solutions, System Strengthening and End Users

All 5 Releases


More Releases for Pharmaceutical

Pharmaceutical Packaging Equipment Market
The Global Pharmaceutical Packaging Equipment Market is expected to grow from USD 62235.24 Millions in 2018 to USD 98562.24 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.78%. Get Free Sample: https://reports.valuates.com/request/sample/360I-Auto-4F48/Global_Pharmaceutical_Packaging_Equipment "Growing pharmaceutical industry in emerging economies is one of the factors largely attributing to the growth of the Global Pharmaceutical Packaging Equipment Market " View Full Report: https://reports.valuates.com/market-reports/360I-Auto-4F48/global-pharmaceutical-packaging The factors attributing to the growth of the
Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil Scope of the Report: This report focuses on the Metronidazole in global market, especially in North
Evolving Pharmaceutical Marketing Strategies
Publisher’s latest report,"Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age. While the pharmaceutical industry readily adopts new technologies to provide medical advancements, it has been much slower to adopt technology within its marketing efforts, mostly relying on traditional channels and methods. However, the decreasing effectiveness of these traditional channels, given changing physician, patient
Vitamin C Market 2017 -CSPC Pharmaceutical Group, DSM, Shandong Luwei Pharmaceut …
Apex Research, recently published a detailed market research study focused on the "Vitamin C Market" across the global, regional and country level. The report provides 360° analysis of "Vitamin C Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Vitamin C industry, and estimates the future trend of Vitamin C market